BiochemistryJournal of Medicinal ChemistryPeer-reviewed
Covalent targeting leads to the development of LIMK1 isoform-selective inhibitors
Sebastian Mandel, Thomas Hanke, Niall Prendiville…·Stefan Knapp
This study develops a covalent LIMK1 inhibitor that selectively targets a unique cysteine, enabling isoform-specific studies of LIMK1 function.